| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1468207A New retinoids for the treatment of emphysema |
| 01/14/2004 | CN1134444C Epothilone analog and medicine combination |
| 01/14/2004 | CN1134433C Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase |
| 01/14/2004 | CN1134431C 2,4-diaminopyrimidine derivatives as dopamine D4 receptor antagonists |
| 01/14/2004 | CN1134421C Antifungal and its preparation method and intermediate |
| 01/14/2004 | CN1134418C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation |
| 01/14/2004 | CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 01/14/2004 | CN1134264C Antithrombotic agents |
| 01/13/2004 | US6677460 Aromatic carboxylic acid bicyclic sulfur compounds |
| 01/13/2004 | US6677365 Antagonists of MCP-1 function and methods of use thereof |
| 01/13/2004 | US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 01/13/2004 | US6677354 Treating sleep, brain, sexual, cardiovascular, nervous system, psychological, glandular, and gastrointestinal disorders |
| 01/13/2004 | US6677340 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/13/2004 | US6677339 S-3-(4-(3,5-dichloropyrid-4-ylcarboxamido)phenyl)-2-(4,6-dimet hoxy-1,3,5-triazin-2-ylamino)propanoic acid for example; inhibit binding of alpha 4 integrins to their ligands, for treating immune or inflammatory disorders |
| 01/13/2004 | US6677333 2H-phthalazin-1-one derivatives and drug containing its derivatives as active ingredient |
| 01/13/2004 | US6677332 Amide-substituted piperidine or azepine derivatives to treat drug abuse and tinnitus |
| 01/13/2004 | US6676909 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 01/08/2004 | WO2004002985A1 Peptidic thrombin inhibitor compound |
| 01/08/2004 | WO2004002977A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002964A1 Diaminopyrimidinecarboxa mide derivative |
| 01/08/2004 | WO2004002948A1 Amide compound and medicinal use thereof |
| 01/08/2004 | WO2003062206A3 Small molecule modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006230 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 01/08/2004 | US20040006229 Indole derivatives for the treatment of depression and anxiety |
| 01/08/2004 | US20040006123 Interleukin-4 gene expression inhibitors |
| 01/08/2004 | US20040006119 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 01/08/2004 | US20040006114 Potentiators of glutamate receptors |
| 01/08/2004 | US20040006105 Thrombin receptor antagonists |
| 01/08/2004 | US20040006104 For therapy and prophylaxis of diseases and conditions associated with undesirable or abnormal inflammatory responses, such as ischemia-reperfusion injury, asthma, arthritis |
| 01/08/2004 | US20040006101 Quinolinone derivatives |
| 01/08/2004 | US20040006094 For prophylaxis of ischemic cell death, particularly neuronal cell death, and reduce the likelihood of neuronal cell death in a subject due to a traumatic event |
| 01/08/2004 | US20040006089 For therapy of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome |
| 01/08/2004 | US20040006087 Method of treating cancer using FPT inhibitors and antineoplastic agents |
| 01/08/2004 | US20040006086 For therapy of metabolic and eating disorders such as obesity and hyperphagia, diabetes |
| 01/08/2004 | US20040006082 For therapy and prophylaxis of diabetes, diabetic complications, diabetic retinopathy, obesity or asthma, hypoglycemic agent, an improving agent for impaired glucose tolerance, a potentiating agent for insulin sensitivity |
| 01/08/2004 | US20040006081 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 01/08/2004 | US20040006080 Chemical compounds |
| 01/08/2004 | US20040006067 Substituted piperidines and methods of use |
| 01/08/2004 | US20040006062 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 01/08/2004 | US20040006047 Heterocyclic amides, a process for their preparation, compositions comprising them and their use |
| 01/08/2004 | CA2489433A1 Inhibitors of hcv ns5b polymerase |
| 01/07/2004 | EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377971A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 01/07/2004 | EP1377556A1 Pyrazole derivatives for treating hiv |
| 01/07/2004 | EP1377555A1 Novel compounds |
| 01/07/2004 | EP1377554A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases |
| 01/07/2004 | EP1377550A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 01/07/2004 | EP1377542A1 Hiv protease inhibitors based on amino acid derivatives |
| 01/07/2004 | EP1377540A1 INHIBITORS OF INTEGRIN AvB6 |
| 01/07/2004 | EP1377283A2 Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 01/07/2004 | EP1103243B1 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives for the treatment of troubles mediated by an excess of substance p |
| 01/07/2004 | EP0748315B1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, these products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same |
| 01/07/2004 | CN1466583A Design and synthesis of advanced NLO materials for electro-optic applications |
| 01/07/2004 | CN1466577A 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 01/07/2004 | CN1133625C Quinazoline derivatives |
| 01/06/2004 | US6673941 Disubstituted imidazoles useful in the treatment of bacterial infections |
| 01/06/2004 | US6673923 Pyrazole antimicrobial agents |
| 01/06/2004 | US6673833 As antitumor agent |
| 01/06/2004 | US6673829 Treatment of diseases of the central nervous system, the peripheral nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system. |
| 01/06/2004 | US6673820 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 01/06/2004 | US6673801 Dihydroxyhexanoic acid derivatives |
| 01/06/2004 | US6673796 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/06/2004 | US6673787 Pyrimidinesulfonamide containing indole compounds used as antiangiogenic and antitumor agents |
| 01/06/2004 | US6673257 Blends employing at least two organic compounds having known melt temperatures, exhibit improved thermal properties and performance characteristics |
| 01/06/2004 | CA2099232C Fluoro taxols |
| 01/02/2004 | EP1375503A1 Dioxino derivatives and their use as dopanine agonists |
| 01/02/2004 | EP1375486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 01/02/2004 | EP1373265A1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 01/02/2004 | EP1373263A1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 01/02/2004 | EP1373262A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors |
| 01/02/2004 | EP1373261A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 01/02/2004 | EP1373259A1 Pyridazinone aldose reductase inhibitors |
| 01/02/2004 | EP1373256A1 Ccr5 antagonists useful for treating aids |
| 01/02/2004 | EP1373251A2 Non-imidazole compounds as histamine h3 antagonists |
| 01/02/2004 | EP1373246A2 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373223A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373221A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373219A1 Thiohydantoins and use thereof for treating diabetes |
| 01/02/2004 | EP1373217A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 01/02/2004 | EP1373210A1 Heterocyclic diamide invertebrate pest control agents |
| 01/02/2004 | EP1373203A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 01/02/2004 | EP1373199A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 01/02/2004 | EP1372657A2 A method of treating proliferative diseases using eg5 inhibitors |
| 01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
| 01/02/2004 | EP0788482B1 Method for preparing esters of halonicotinic acids |
| 01/01/2004 | US20040002534 Stem cell factor; signal transduction passageways; anticancer agents |
| 01/01/2004 | US20040002528 CBI analogs of CC-1065 and the duocarmycins |
| 01/01/2004 | US20040002527 Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| 01/01/2004 | US20040002525 Obesity; osteoporosis |
| 01/01/2004 | US20040002524 Cardiovascular disorders; osteoporosis; central nervous system disorders |
| 01/01/2004 | US20040002508 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 01/01/2004 | US20040002504 Psychological disorders; schizophrenia |
| 01/01/2004 | US20040002494 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 01/01/2004 | US20040002492 ATM inhibitors |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |